[Radiofrequency ablation for verapamil-sensitive ventricular tachycardia]
Yong Xie1, Su-Rong Meng, Jian Peng
1Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou 510515,China.
Radiofrequency catheter ablation effectively treats verapamil-sensitive ventricular tachycardia (VT) with a low recurrence rate. This procedure offers a safe and curative option for patients with this specific type of VT.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Verapamil-sensitive ventricular tachycardia (VT) is a specific arrhythmia.
- Identifying effective and safe treatment options for VT is crucial.
Purpose of the Study:
- To evaluate the efficacy and safety of radiofrequency catheter ablation for verapamil-sensitive VT.
- To determine the success rate and complication profile of the procedure.
Main Methods:
- 18 patients with verapamil-sensitive VT underwent radiofrequency catheter ablation.
- Ablation targeted Purkinje potentials preceding the QRS complex by at least 20 ms.
- Programmed stimulation was used post-ablation to assess efficacy.
Main Results:
- Successful ablation was achieved in all 18 patients, with VT no longer inducible.
- The optimal ablation target was a Purkinje potential preceding the QRS by 24.0 ± 3.5 ms.
- A low recurrence rate of 11.1% was observed during 3-6 months follow-up, with minor hematoma in 2 patients.
Conclusions:
- Radiofrequency ablation is a safe and effective treatment for verapamil-sensitive VT.
- The procedure demonstrates a low recurrence rate, offering a curative approach.
- Further research may explore long-term outcomes and management of transient resistance.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
28:13Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
